Drug Topics
OCTOBER 16, 2023
Lisa Faast, CEO and Owner of DiversifyRx, discusses ways that pharmacists can prepare their business for the cash crunch that is set to happen in the first several months of next year.
PharmaVoice
OCTOBER 16, 2023
Billionaire investors and a new crop of longevity biotechs are betting big money on a lifespan-altering tipping point.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 16, 2023
Britney Beck, founder and chief people strategist at Hi-Wire HR Consulting, discusses how pharmacists can navigate the current challenges in the labor market.
PharmaVoice
OCTOBER 16, 2023
Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 16, 2023
The winner was announced during the 2023 NCPA Annual Convention and Expo.
Pharmacy Times
OCTOBER 16, 2023
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
OCTOBER 16, 2023
With Halloween just around the corner, now is the perfect time to discuss how medicine was, and still can be, sweet.
STAT
OCTOBER 16, 2023
Hospitals are frustrated with a nationwide nursing shortage that’s only gotten worse since the pandemic. In 2022, the American Hospital Association quoted an estimate that half a million nurses would leave the field by the end of that year, bringing the total shortage to 1.1 million. At the same time, National Nurses United insists there isn’t a nurse shortage at all.
Pharmacy Times
OCTOBER 16, 2023
Rite Aid filed for bankruptcy protection and said it plans to close several hundred retail stores.
STAT
OCTOBER 16, 2023
The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed. Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 16, 2023
Investigators created a model to predict asthma exacerbations that can be integrated in WhatsApp chatbot and relies on self-reported data.
Fierce Pharma
OCTOBER 16, 2023
Up until this point, immune checkpoint inhibitors have been allowed to treat early-stage non-small cell lung cancer (NSCLC) either before or after surgery. | Thanks to a new FDA approval for Merck's Keytruda, a continuous immunotherapy regimen around surgery is now available for patients with early-stage non-small cell lung cancer. The drug's label already includes an overall survival win from a key trial.
Fierce Healthcare
OCTOBER 16, 2023
Hundreds of Allina Health physicians have voted in favor of unionizing, creating what their representation believes to be the largest collection of unionized private-sector physicians in the countr | Primary and urgent care clinicians' 325-200 vote was announced late last week and follows another in-favor unionization push by Allina Health inpatient physicians earlier this year.
PharmaVoice
OCTOBER 16, 2023
A few key meetings remain this year, like ESMO and ASH, while next year’s events are already being planned. Here’s a list of conferences to keep in mind.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
OCTOBER 16, 2023
A research brief out of think tank Urban Institute evaluates the prospect of reducing Medicare spending by reining in excessive post-acute care rates. | New research shows that MedPAC's previous proposal for a unified payment structure for post-acute care could save Medicare billions.
Pharmacy Times
OCTOBER 16, 2023
Maintaining a strict work-life balance, setting boundaries, and trusting instincts can help technicians manage a challenging workplace.
Fierce Healthcare
OCTOBER 16, 2023
The National Community Pharmacists Association (NCPA) has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees. | The National Community Pharmacists Association has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees.
Pharmacy Times
OCTOBER 16, 2023
A subcutaneous injection of ocrelizumab was markedly effective at suppressing brain lesions in patients with multiple sclerosis, according to data from a phase 3 trial.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
OCTOBER 16, 2023
Rite Aid has received a commitment for $3.45 billion in new financing; names Jeffrey Stein as CEO, succeeding Elizabeth Burr, who has served as interim CEO since January 2023.
pharmaphorum
OCTOBER 16, 2023
Patient Centricity to Integration: Enhancing Cancer Outcomes Mike.
Pharmacy Times
OCTOBER 16, 2023
In clinical trials, nivolumab (Opdivo) demonstrated a statistically significant improvement in recurrence-free survival compared to placebo in eligible patients with stages IIB, IIC, III, and stage IV completely resected melanoma.
pharmaphorum
OCTOBER 16, 2023
Bayer adds QR code to pack to help blind patients Phil.
STAT
OCTOBER 16, 2023
Steroids were once the only treatment option for some chronic conditions. Today, many other treatments exist, but doctors often stick with the tried-and-true steroids. There are good reasons for this: They are low-cost and readily approved by insurance companies. But while generally safe for short-term use, long-term steroids pose significant dangers.
Fierce Healthcare
OCTOBER 16, 2023
California Gov. Gavin Newsom signed into law Friday a bill that raises the minimum wage for healthcare workers to $25 per hour across the state over the next several years. | The law is estimated to bring more than $10,000 per year in wage increases for about 450,000 of the Golden State’s low-wage healthcare workers. It requires provider organizations to incrementally raise minimum wages at different rates depending on their size and type.
The FDA Law Blog
OCTOBER 16, 2023
By Gail H. Javitt & Steven J. Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products. The first article—“Is the Eye the Window to Alzheimer’s?
STAT
OCTOBER 16, 2023
In the latest tussle over the cost of medicines, Teva Pharmaceuticals has filed a lawsuit alleging that a new Colorado program aimed at making epinephrine auto-injectors more affordable violates its constitutional rights. The lawsuit was filed in response to a state law that was passed in August and requires health insurers that provide coverage for these injectors to cap out-of-pocket costs to $60 for a package of two injectors.
pharmaphorum
OCTOBER 16, 2023
The UK market: A land of new opportunities for medical device manufacturers Mike.
STAT
OCTOBER 16, 2023
People with obesity often go underrepresented in drug development trials, a critical gap that researchers say leaves drugmakers and doctors unsure of efficacy or risks in that patient population. “Patients and providers are not aware of how some drugs may act differently in people with obesity,” said Christina Chow, the head of research at Emerald Lake Safety, an institution that conducts independent research to make pharmaceuticals safer.
Fierce Healthcare
OCTOBER 16, 2023
There's another shake-up at the top for CVS Health, the retail health giant announced Monday. | There's another shake-up at the top for CVS Health, the retail health giant announced Monday.
pharmaphorum
OCTOBER 16, 2023
AZ’s Tagrisso plus chemo get fast FDA review for lung cancer Phil.
STAT
OCTOBER 16, 2023
CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown. The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise.
pharmaphorum
OCTOBER 16, 2023
Novo Nordisk cuts $1.3bn deal for KBP blood pressure drug Phil.
Drug Store News
OCTOBER 16, 2023
Thomas Cowhey, senior vice president of corporate finance, has been appointed interim CFO, while CEO of Oak Street Health Mike Pykosz has been named interim president of Health Services.
Expert insights. Personalized for you.
568 
Let's personalize your content